AVITA Medical Announces FDA Approval of the RECELL® System for the Treatment of Severe Burns in the U.S.
AVITA Medical, a global regenerative medicine company, announced that the U.S. Food and Drug Administration (FDA) approved the Company’s Premarket Approval…
- Statement from FDA Commissioner Scott Gottlieb, M.D., on efforts to safeguard women’s health from deceptive health claims and significant risks related to devices marketed for use in medical procedures for “vaginal rejuvenation”
- FDA approves new treatment for a rare genetic disorder, Fabry disease
- Cynosure Receives FDA 510(k) Clearance for SculpSure™, the World's First Hyperthermic Laser Treatment for Non-Invasive Fat Reduction